TW200616618A - Novel compound, manufacturing method thereof, and pharmaceutical composition containing the same - Google Patents

Novel compound, manufacturing method thereof, and pharmaceutical composition containing the same

Info

Publication number
TW200616618A
TW200616618A TW094130287A TW94130287A TW200616618A TW 200616618 A TW200616618 A TW 200616618A TW 094130287 A TW094130287 A TW 094130287A TW 94130287 A TW94130287 A TW 94130287A TW 200616618 A TW200616618 A TW 200616618A
Authority
TW
Taiwan
Prior art keywords
same
manufacturing
composition containing
pharmaceutical composition
novel compound
Prior art date
Application number
TW094130287A
Other languages
Chinese (zh)
Inventor
Satoshi Murata
Satoshi Tatemichi
Kumi Kobayashi
Masaaki Ban
Minoru Kubota
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of TW200616618A publication Critical patent/TW200616618A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A preventive or remedy for dysuria containing a compound represented by the following general formula (1) or a pharmaceutically acceptable salt thereof, or a hydrate or solvate either, a process for manufacturing the same and a medicinal composition containing the same: , (wherein R is a halogen atom, cyano group or aryl group which may have a lower alkyl group.) The compound of the present invention is useful for an excellent preventive and/or remedy for dysuria, because it has highly potent affinity for alphalA-adrenaline receptor subtype among alphalA, alphalB and alphalD-adrenaline receptor subtypes.
TW094130287A 2004-09-06 2005-09-05 Novel compound, manufacturing method thereof, and pharmaceutical composition containing the same TW200616618A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004257883 2004-09-06

Publications (1)

Publication Number Publication Date
TW200616618A true TW200616618A (en) 2006-06-01

Family

ID=36036272

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094130287A TW200616618A (en) 2004-09-06 2005-09-05 Novel compound, manufacturing method thereof, and pharmaceutical composition containing the same

Country Status (3)

Country Link
JP (1) JP4847333B2 (en)
TW (1) TW200616618A (en)
WO (1) WO2006027987A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600675B1 (en) * 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
CA2382683A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols

Also Published As

Publication number Publication date
JP4847333B2 (en) 2011-12-28
WO2006027987A1 (en) 2006-03-16
JPWO2006027987A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
SE0400284D0 (en) Novel compounds
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
ATE303387T1 (en) CONDENSED IMIDAZOLE DERIVATIVES AND DRUGS FOR DIABETES MELLITUS
EP1829858A3 (en) Dibenzylamine compounds and pharmaceutical use thereof
MY141559A (en) Triazole derivatives as tachykinin receptor antagonists
MXPA03011638A (en) 4-piperazinylindole derivatives with 5-ht6 receptor affinity.
MX2007012936A (en) Dihydrobenzofuran derivatives and uses thereof.
ZA200700765B (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
WO2003084938A3 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
PH12014500937A1 (en) 5-ht 1a receptor substype agonist
NO20076060L (en) Piperidin-4-yl amide derivatives and their use as SST receptor subtype 5 antagonists
WO2004089366A8 (en) Bicyclic compounds as nr2b receptor antagonists
WO2008101935A3 (en) New indole derivative compounds and pharmaceutical compositions containing the same
MXPA04002338A (en) Carbazole derivatives and their use as npy5 receptor antagonists.
TW200640900A (en) 1-(2h)-isoquinolone derivative
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2006057922A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
DE602004020730D1 (en) PHARMACEUTICAL PROCESS AND COMPOUNDS MADE THEREFOR
WO2005003087A3 (en) Oxazole derivatives as antibacterial agents
TW200619212A (en) Morpholine derivatives
DE60330758D1 (en) CERTAIN PHARMACEUTICALLY VALUABLE SUBSTITUTED AMINO ALKYL HETEROCYCLES
MXPA04005426A (en) Ring fused pyrazole derivatives.
WO2004029064A8 (en) (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
TW200637539A (en) CTGF inhibitors